Detection of ovarian cancer via the spectral fingerprinting of quantum-defect-modified carbon nanotubes in serum by machine learning
Open accessAbstract
Serum biomarkers are often insufficiently sensitive or specific to facilitate cancer screening or diagnostic testing. In ovarian cancer, the few established serum biomarkers are highly specific, yet insufficiently sensitive to detect early-stage disease and to impact the mortality rates of patients with this cancer. Here we show that a 'disease fingerprint' acquired via machine learning from the spectra of near-infrared fluorescence emissions of an array of carbon nanotubes functionalized with quantum defects detects high-grade serous ovarian carcinoma in serum samples from symptomatic individuals with 87% sensitivity at 98% specificity (compared with 84% sensitivity at 98% specificity for the current best clinical screening test, which uses measurements of cancer antigen 125 and transvaginal ultrasonography). We used 269 serum samples to train and validate several machine-learning classifiers for the discrimination of patients with ovarian cancer from those with other diseases and from healthy individuals. The predictive values of the best classifier could not be attained via known protein biomarkers, suggesting that the array of nanotube sensors responds to unidentified serum biomarkers.
AI snapshot
Written from the paper’s full text.
TL;DR
An array of quantum-defect-modified carbon nanotube nanosensors plus machine learning detects high-grade serous ovarian carcinoma from serum with 87% sensitivity at 98% specificity, exceeding the CA125/transvaginal-ultrasound benchmark of 84% sensitivity at 98% specificity. The sensor responses appear to capture known and unidentified serum biomarkers.
Key findings
- The best SVM model, using five OCC-DNAs, achieved 93.9% sensitivity, 95.2% specificity and an F-score of 0.945 in 10-fold cross-validation for HGSOC versus all other disease plus healthy samples; an independent 54-sample test set gave 100% sensitivity at 98% specificity and an F-score of 0.978.
- The optimized prediction model yielded 87% sensitivity at 98% specificity when PPV and sensitivity were equally weighted, compared with 84% sensitivity at 98% specificity for the current best clinical screening test using CA125 and transvaginal ultrasonography.
- Conventional biomarkers underperformed: CA125 screening with a 50 U ml−1 cutoff gave 65.3% sensitivity, 88.3% specificity and an F-score of 0.621; logistic regression of additional biomarkers only marginally improved HGSOC prediction.
- The sensor array responded quantitatively to CA125, HE4, YKL40 and bilirubin; SVR models gave r2 values of 0.719 for CA125, 0.55 for HE4 and 0.56 for YKL40, but biomarker-dependent features did not fully account for predictive value, suggesting unidentified biomarkers contribute.
Methods
- OCC-DNA nanosensors were synthesized by introducing organic colour centres to (6,5)-SWCNTs via diazonium chemistry and encapsulating them with ssDNA; ten combinations were made from three OCCs and four DNA sequences, six with P < 0.10 were selected, and the best SVM used five.
- The study used 269 serum samples from female patients: 215 for training/validation (49 HGSOC, 51 other gynaecologic diseases, 29 non-gynaecologic cancer, 25 remission including 7 HGSOC, 61 healthy donors) and 54 independent test samples (7 HGSOC, 5 other gynaecologic diseases, 32 non-gynaecologic diseases, 10 healthy). Spectra were collected at 2 h, 24 h and 72 h; features were dint, dint*, dwl and dwl*.
- Logistic regression, decision tree, artificial neural networks, random forest and SVM were trained with Bayesian hyperparameter optimization and 10-fold cross-validation; SVM/SVR used a radial basis function kernel, and external validation used the independent sample set. PROBAST was used to assess risk of bias.
Limitations
- Stated: specimens were obtained from symptomatic individuals at diagnosis, so prediction outcomes will be lower in the clinical screening setting with asymptomatic individuals; further studies are needed to evaluate pre-invasive and early-invasive disease.
- Stated: the limited medical record of healthy donors and the enriched fraction of breast cancers in the non-HGSOC group of the test set may introduce systematic bias in participant selection and validation.
- Stated and evident: the biomarkers and molecular interactions primarily responsible for the disease fingerprint are unknown and largely cannot be determined by current machine-learning methods; the independent test set was small (54 samples, 7 HGSOC), limiting external validation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 35 cited sources checked · 0 supported · 0 flagged
- Findingown data
The predictive values of the best classifier could not be attained via known protein biomarkers.
“The predictive values of the best classifier could not be attained via known protein biomarkers, suggesting that the array of nanotube sensors responds to unidentified serum biomarkers.”
Quote in the paperSubstantial claim - Findingown data
The OCC-DNA nanosensor array with machine learning detects high-grade serous ovarian carcinoma in serum samples from symptomatic individuals with 87% sensitivity at 98% specificity.
“Here we show that a ‘disease fingerprint’ acquired via machine learning from the spectra of near-infrared fluorescence emissions of an array of carbon nanotubes functionalized with quantum defects detects high-grade serous ovarian carcinoma in serum samples from symptomatic individuals with 87% sensitivity at 98% specificity”
- Also stated in: § Results · plain
“yielded 87% sensitivity at 98% specificity when PPV and sensitivity were equally weighted (β = 1).”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Findingown data
SVM resulted in the best F-scores among the five machine learning algorithms tested.
“We found that SVM resulted in the best F-scores among the 5 machine learning algorithms that we tested”
Quote in the paperSubstantial claim - Findingnone given
The sensor technology does not rely on antibody-based molecular recognition elements.
“Fourth, because the technology does not rely on antibody-based molecular recognition elements, the sensors could be more robust than existing methods (Supplementary Fig. 4), enabling use in resource-limited settings and in technologies such as point-of-care and wearable/implantable devices42.”
Quote in the paperSubstantial claim - Findingown data
Each OCC-DNA nanosensor featured a pair of emission peaks that depend on the chemical nature of the OCC and DNA sequence.
“Each OCC-DNA nanosensor featured a pair of emission peaks that depend on the chemical nature of the OCC and DNA sequence.”
Quote in the paperSubstantial claim
- Findingown data
The sensor technology identified HGSOC with high positive and negative predictive values.
“The sensor technology was used to identify HGSOC with high positive and negative predictive values.”
Quote in the paperSubstantial claim - Findingown data
The data did not delineate a clear difference between HGSOC and other disease conditions.
“but the data did not delineate a clear difference between HGSOC and other disease conditions”
Quote in the paperSubstantial claim - Findingown data
There were no statistically significant differences between incubation times in all tested machine learning algorithms.
“In all the tested machine learning algorithms, there were no statistically significant differences between incubation times”
Quote in the paperSubstantial claim - Findingown data
Six OCC-DNA nanosensors exhibiting E11 or E11− peak wavelengths with statistically significant differences between HGSOC and healthy groups (P < 0.10) were selected for the sensor array.
“Six OCC-DNA nanosensors exhibiting E11 or E11− peak wavelengths with statistically significant differences between HGSOC and healthy groups (P < 0.10) were selected for the sensor array used in the subsequent parts of this study”
Quote in the paperSubstantial claim - Findingown data
The best SVM model was trained by the spectral response of 5 OCC-DNAs: NEt2*CTTC3TTC, NEt2*(TAT)4, 3F*(TAT)4, 3F*(AT)15 and 3F*(GT)15.
“The best SVM model was trained by the spectral response of 5 OCC-DNAs: NEt2*CTTC3TTC, NEt2*(TAT)4, 3F*(TAT)4, 3F*(AT)15 and 3F*(GT)15.”
Quote in the paperSubstantial claim - Findingown data
The optical responses of OCC-DNA nanosensors did not provide substantial predictive value to differentiate HGSOC from other diseases and healthy individuals using conventional statistical analyses.
“but the optical responses did not provide substantial predictive value to differentiate these patients using conventional statistical analyses.”
Quote in the paperSubstantial claim - Findingown data
The trend of increasing F-scores with more OCC-DNA elements was the same regardless of which machine learning algorithm was used.
“The trend was the same regardless of which machine learning algorithm was used”
Quote in the paperNot a substantial claim - Findingown data
All four spectroscopic variables-int, int*, wl, wl*-measured from the OCC-DNA nanosensor array exhibited statistically significant differentiation between HGSOC and healthy groups.
“All four spectroscopic variables—int, int*, wl, wl*—measured from the OCC-DNA nanosensor array, exhibited statistically significant differentiation between HGSOC and healthy groups”
Quote in the paperSubstantial claim - Findingown data
When more OCC-DNA elements were added to the sensor array, the F-scores tended to increase systematically.
“When more OCC-DNA elements were added to the sensor array, the F-scores tended to increase systematically.”
Quote in the paperSubstantial claim - Findingown data
The emission of OCC-DNA nanosensors exhibited diverse responses to serum samples from HGSOC patients, other non-HGSOC diseases, and healthy individuals.
“The emission of the OCC-DNA nanosensors exhibited diverse responses to serum samples collected from patients with high-grade serous ovarian carcinoma (HGSOC), other non-HGSOC diseases (including patients in remission, other gynaecologic processes such as endometriosis and low-grade ovarian carcinoma, non-gynaecologic cancers, and other conditions) and healthy individuals”
Quote in the paperSubstantial claim - Findingreasoning
Interactions between HGSOC serum biomarkers and OCC-DNA hybrids elicited diverse spectral responses of the sensor array that enabled sufficient differentiation of signals from other sera.
“Interactions between HGSOC serum biomarkers and OCC-DNA hybrids elicited diverse spectral responses of the sensor array that enabled sufficient differentiation of signals from other sera.”
Quote in the paperSubstantial claim - Findingcitation
Model performance of the sensor technology exceeds the results of the current best clinical screening test using longitudinal CA125 and second-line transvaginal ultrasonography (87% vs 84% clinical sensitivities at 98% specificity).
“Model performance of the sensor technology exceeds the results of the current best clinical screening test using longitudinal CA125 and second-line transvaginal ultrasonography9 (87% vs 84% clinical sensitivities at 98% specificity).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Jacobs, I. J. et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 387, 945–956 (2016). source
Not checked in the free run.
- Findingreasoning
There was no statistically significant difference between 4 and 6 variables in the F-scores of the optimized SVM models.
“We found no statistically significant difference between 4 and 6 variables in the F-scores of the optimized SVM models”
Quote in the paperSubstantial claim - Findingown data
SVM models trained with the data set of 2 variables, Δint and Δwl, resulted in lower F-scores.
“The SVM models trained with the data set of 2 variables, Δint and Δwl, resulted in lower F-scores.”
Quote in the paperSubstantial claim - Premisecitation
Stand-alone serum biomarker measurements have proven of little survival benefit due to limited specificity and low positive predictive value.
“However, stand-alone biomarker measurements have proven of little survival benefit due to limited specificity and low positive predictive value (PPV)7,8.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Hertlein, L. et al. Human epididymis protein 4 (HE4) in benign and malignant diseases. Clin. Chem. Lab. Med. 50, 2181–2188 (2012). source
Not checked in the free run.
- cites [8] Pinsky, P. F. et al. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecol. Oncol. 143, 270–275 (2016). source
Not checked in the free run.
- Interpretationreasoning
The array of nanotube sensors responds to unidentified serum biomarkers.
“suggesting that the array of nanotube sensors responds to unidentified serum biomarkers.”
- Also stated in: § Results · hedged
“These experiments suggest that the OCC-DNA nanosensor array results may be due, at least in part, to the transduction of heretofore unidentified biomarkers.”
Quote in the paperSubstantial claim - Also stated in: § Results · hedged
- Interpretationown data
The OCC-DNA sensor array with machine learning outperforms the current best clinical screening test for HGSOC detection.
“compared with 84% sensitivity at 98% specificity for the current best clinical screening test, which uses measurements of cancer antigen 125 and transvaginal ultrasonography”
- Also stated in: § Results · boosted
“These results confirmed that our perception/sensor-based technology substantially outperformed established serum biomarker-based classification, and the accuracy was much closer to diagnosis by a physician (using pathology, imaging and so on).”
Quote in the paperSubstantial claim- Rests on an assumption: The current best clinical screening test uses CA125 and transvaginal ultrasonography and has 84% sensitivity at 98% specificity.
- Also stated in: § Results · boosted
- Premisecitation
Serum biomarkers are often insufficiently sensitive or specific to facilitate cancer screening or diagnostic testing.
“Serum biomarkers are often insufficiently sensitive or specific to facilitate cancer screening or diagnostic testing.”
- Also stated in: § Abstract · boosted
“stand-alone biomarker measurements have proven of little survival benefit due to limited specificity and low positive predictive value (PPV)7,8”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Hertlein, L. et al. Human epididymis protein 4 (HE4) in benign and malignant diseases. Clin. Chem. Lab. Med. 50, 2181–2188 (2012). source
Not checked in the free run.
- cites [8] Pinsky, P. F. et al. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecol. Oncol. 143, 270–275 (2016). source
Not checked in the free run.
- Also stated in: § Abstract · boosted
- Study design and conductown data
The optimized SVM model was evaluated on an independent test set of 54 patient samples.
“we synthesized a new batch of OCC-DNAs under the same condition and collected the sensor array response data to an independent test set of 54 patient samples (Nsa = 54).”
Quote in the paperSubstantial claim - Study design and conductown data
The risk of bias scored low in terms of predictors, outcomes and analyses.
“The risk of bias scored low in terms of predictors, outcomes and analyses.”
Quote in the paperNot a substantial claim - Study design and conductown data
The variation of each measurement from the averaged triplicates was small for all OCC-DNA peaks.
“We note that the variation of each measurement from the averaged triplicates was small for all the OCC-DNA peaks”
Quote in the paperSubstantial claim - Interpretationown data
Small variances in F-score and sensitivity (<0.1) in cross-validations suggest that the optimized models are generalizable within the sample set.
“Small variances in F-score and sensitivity (<0.1) in cross-validations suggest that the optimized models are generalizable within the sample set.”
Quote in the paperSubstantial claim - Study design and conductown data
The measurement can reliably identify small spectral shifts.
“The analysis confirmed that our measurement can reliably identify the small spectral shifts.”
Quote in the paperSubstantial claim - Premisecitation
Currently, no screening strategy can identify ovarian cancer at an early enough stage to reduce mortality.
“Currently, no screening strategy can identify disease at an early enough stage to reduce mortality10.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Menon, U. et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 397, 2182–2193 (2021). source
Not checked in the free run.
- Interpretationown data
There exist potential biomarkers or combinations thereof that are either unknown or not part of conventional screening approaches but were captured by the OCC-DNA sensor array.
“This suggests that there exist potential biomarkers or combinations thereof that are either unknown or not part of conventional screening approaches but were captured by the OCC-DNA sensor array.”
Quote in the paperSubstantial claim- Rests on an assumption: The spectroscopic variables that are not sensitive to known biomarkers reflect the presence of unknown biomarkers or combinations thereof.
- Premisecitation
Information detailing which biomarkers and molecular interactions primarily result in the disease fingerprint is unknown and largely cannot be determined by current machine-learning methods.
“Information detailing which biomarkers and molecular interactions primarily result in the disease fingerprint is unknown and largely cannot be determined by current machine-learning methods43.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] Zednik, C. Solving the Black Box Problem: a normative framework for explainable artificial intelligence. Philos. Technol. 34, 265–288 (2021). source
Not checked in the free run.
- May combine two claims. 23
- Classified as probably not a substantial claim. 22
May combine two claims.
Findingown dataPrincipal component analysis of spectroscopic data showed healthy samples segregated into separate regions from disease samples, but HGSOC could not be separated from other disease conditions.
“Similar to Fig. 2c, healthy samples showed the differentiable signatures from the disease samples, denoted by their segregation into separate regions in the PCA plot (Fig. 2d), but HGSOC could not be separated from the other disease conditions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe first two principal components accounted for 87.5% of the total variance.
“The first two principal components accounted for 87.5% of the total variance”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWith the independent test set, the optimized SVM model resulted in 100% sensitivity at 98% specificity and an F-score of 0.978.
“With this new sample set, the optimized SVM model resulted in 100% sensitivity at 98% specificity and an F-score of 0.978.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt decreasing β from 3 to 0.2, sensitivity at 98% specificity systematically increased, although the improvement was statistically non-significant between μ values of 0.2, 0.5, 0.8 and 1.
“At decreasing β from 3 to 0.2, sensitivity at 98% specificity systematically increased, although the improvement was statistically non-significant between μ values of 0.2, 0.5, 0.8 and 1 in this study”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenThe sensor technology can be used in a high-throughput fashion to facilitate the screening of large populations.
“Third, this sensor technology can be used in a high-throughput fashion to facilitate the screening of large populations.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCombining datasets obtained over multiple incubation durations could improve model performance, but the performance was only marginally better than using 2 h of serum incubation.
“We found that combining datasets obtained over multiple incubation durations could improve the model performance, but the performance was only marginally better than using 2 h of serum incubation”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSupport vector machine models resulted in excellent sensitivity and specificity of HGSOC detection, with an accuracy approaching 95%, outperforming conventional serum biomarker-based identification.
“Support vector machine models resulted in excellent sensitivity and specificity of HGSOC detection, with an accuracy approaching 95%, outperforming conventional serum biomarker-based identification.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe best-performing prediction model was the sensor array combination of 4-N(C2H5)2*C T2C3T2C, 4-N(C2H5)2*(TAT)4, 3,4,5-F3*(TAT)4, 3,4,5-F3*(AT)15 and 3,4,5-F3*(GT)15, and yielded 87% sensitivity at 98% specificity when PPV and sensitivity were equally weighted (β = 1).
“The best-performing prediction model was the sensor array combination of 4-N(C2H5)2*C T2C3T2C, 4-N(C2H5)2*(TAT)4, 3,4,5-F3*(TAT)4, 3,4,5-F3*(AT)15 and 3,4,5-F3*(GT)15, and yielded 87% sensitivity at 98% specificity when PPV and sensitivity were equally weighted (β = 1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe averaged cross-validation score of the SVM model was 93.9% sensitivity, 95.2% specificity, and an F-score of 0.945 differentiating HGSOC from all other disease + healthy samples.
“The averaged cross-validation score of the SVM model was 93.9% sensitivity, 95.2% specificity, and an F-score of 0.945 differentiating HGSOC from all other disease + healthy samples.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
FindingreasoningThe materials needed for the sensor cost approximately $5 per sample because of the small amount of OCC-DNAs needed for screening (<5 ng).
“The materials needed for the sensor cost approximately $5 per sample because of the small amount of OCC-DNAs needed for screening (<5 ng).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone givenThe OCC-DNAs remained colloidally stable when kept at 4 °C until used (up to 6 months).
“The OCC-DNAs were kept at 4 °C until used (up to 6 months) as the OCC-DNAs remained colloidally stable.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe best-performing HGSOC prediction model included spectroscopic variables that were not sensitive to the known biomarkers, and their relative importance was much more significant than the biomarker-related variables.
“It is important to note that the best-performing HGSOC prediction model (Fig. 3d) included the spectroscopic variables that were not sensitive to the known biomarkers, and their relative importance was much more significant than the biomarker-related variables (Extended Data Fig. 7).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFeature importance of the prediction models shows which spectral parameters most impacted the model performance using an ablation study.
“Feature importance of the prediction models shows which spectral parameters most impacted the model performance using an ablation study.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn ovarian cancer, established serum biomarkers are highly specific but insufficiently sensitive to detect early-stage disease and to impact mortality.
“In ovarian cancer, the few established serum biomarkers are highly specific, yet insufficiently sensitive to detect early-stage disease and to impact the mortality rates of patients with this cancer.”
- Also stated in: § Abstract · plain
“As established serum biomarkers do not sufficiently represent the ovarian cancer disease state and are not sensitive enough to achieve precise early diagnosis to benefit survival rates10”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Menon, U. et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 397, 2182–2193 (2021). source
Not checked in the free run.
- Also stated in: § Abstract · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPerception-based approaches have been used to classify various disease conditions on the basis of patterns in DNA methylation, volatile organic compounds, small metabolites, and imaging data.
“Perception-based approaches have been used to classify various disease conditions on the basis of different patterns in methylation of DNA sequencing13, volatile organic compounds using electronic noses14, small metabolites using mass spectrometry15, and image analysis of pathology, computerized tomography scans and magnetic resonance imaging data16,17.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [13] Liu, M. C. et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31, 745–759 (2020). source
Not checked in the free run.
- cites [14] Hao, Y. et al. Detection of volatile organic compounds in breath as markers of lung cancer using a novel electronic nose. Proc. IEEE Sens. 2, 1333–1337 (2003).
Not checked in the free run.
- cites [15] Zhang, J. et al. Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system. Sci. Transl. Med. 9, eaan3968 (2017). source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationLongitudinal CA125 measurements combined with transvaginal ultrasonography improve positive predictive value for ovarian cancer detection, but the benefit of screening is still elusive.
“Longitudinal CA125 measurements combined with transvaginal ultrasonography, result in improved PPV for ovarian cancer detection, but the benefit of screening is still elusive9,10.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Jacobs, I. J. et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 387, 945–956 (2016). source
Not checked in the free run.
- cites [10] Menon, U. et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 397, 2182–2193 (2021). source
Not checked in the free run.
May combine two claims.
PremisecitationSemiconducting single-walled carbon nanotubes exhibit intrinsic near-infrared fluorescence with environmental responsivity down to the single-molecule level.
“Semiconducting single-walled carbon nanotubes (SWCNTs) exhibit intrinsic near-infrared fluorescence19 with environmental responsivity down to the single-molecule level20.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [19] Bachilo, S. M. et al. Structure-assigned optical spectra of single-walled carbon nanotubes. Science 298, 2361 (2002). source
Not checked in the free run.
- cites [20] Cognet, L. et al. Stepwise quenching of exciton fluorescence in carbon nanotubes by single-molecule reactions. Science 316, 1465 (2007). source
Not checked in the free run.
May combine two claims.
PremisecitationFluorescence modulation of single-walled carbon nanotubes is caused by several mechanisms, including Fermi level shifting through modulation of the immediate redox environment, exciton disruption in response to binding events, and solvatochromic shifting due to perturbation of the local dielectric environment.
“The fluorescence modulation of SWCNTs is caused by several mechanisms, including Fermi level shifting through modulation of the immediate redox environment and exciton disruption in response to binding events, which change SWCNT intensity, and solvatochromic (wavelength) shifting due to perturbation of the local dielectric environment, including shifts due to modulation of the local electrostatic”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24] Roxbury, D., Jena, P. V., Shamay, Y., Horoszko, C. P. & Heller, D. A. Cell membrane proteins modulate the carbon nanotube optical bandgap via surface charge accumulation. ACS Nano 10, 499–506 (2016). source
Not checked in the free run.
- cites [40] Heller, D. A. et al. Peptide secondary structure modulates single-walled carbon nanotube fluorescence as a chaperone sensor for nitroaromatics. Proc. Natl Acad. Sci. USA 108, 8544 (2011). source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe sensor elements' responses to known biomarkers did not account for all of the predictive value, suggesting that unknown biomarkers play an important role in the differentiation of HGSOC by the sensors.
“but they did not account for all of the predictive value, suggesting that unknown biomarkers play an important role in the differentiation of HGSOC by the sensors.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe independent test set values are consistent with cross-validation scores and gave a similar ROC curve, indicating that the model did not overfit the data.
“These values are consistent with the cross-validation scores and gave a similar receiver operating characteristic (ROC) curve (Fig. 3e), indicating that the model did not overfit the data.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataFor robustness, the study investigated five standard machine learning algorithms with nested levels of optimization processes: model hyperparameters, model choice and multilevel validation.
“For robustness, we investigated five standard machine learning algorithms with nested levels of optimization processes: model hyperparameters, model choice and multilevel validation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationOrganic colour centres (OCCs) are molecularly tunable quantum defects on SWCNTs produced by covalent functionalization.
“Organic colour centres (OCCs) are molecularly tunable quantum defects on SWCNTs, which are produced by covalent functionalization of SWCNTs30,31.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [30] Brozena, A. H., Kim, M., Powell, L. R. & Wang, Y. Controlling the optical properties of carbon nanotubes with organic colour-centre quantum defects. Nat. Rev. Chem. 3, 375–392 (2019). source
Not checked in the free run.
- cites [31] Piao, Y. M. et al. Brightening of carbon nanotube photoluminescence through the incorporation of sp3 defects. Nat. Chem. 5, 840–845 (2013). source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenThe averaged F-score in 10-fold cross-validation was used to assess model performance.
“The averaged F-score in 10-fold cross-validation was used to assess the model performance”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenPotential interferents, such as drug treatments, were accounted for.
“Potential interferents, such as drug treatments, were accounted for.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOCC fluorescence is molecularly specific and extremely sensitive to the local chemical environment of the atomic defect sites.
“OCC fluorescence, on the other hand, is molecularly specific and extremely sensitive to the local chemical environment of the atomic defect sites32,41.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [32] Kwon, H. et al. Optical probing of local pH and temperature in complex fluids with covalently functionalized, semiconducting carbon nanotubes. J. Phys. Chem. C 119, 3733–3739 (2015). source
Not checked in the free run.
- cites [41] Wu, X., Kim, M., Qu, H. & Wang, Y. Single-defect spectroscopy in the shortwave infrared. Nat. Commun. 10, 2672 (2019). source
Not checked in the free run.
May combine two claims.
PremisecitationNon-covalent encapsulation of SWCNTs with polymers, including short oligonucleotides, facilitates aqueous suspension and confers molecular selectivity to their optical responses via a molecular masking effect and modulation of optical bandgaps.
“Non-covalent encapsulation with polymers, including short oligonucleotides, facilitates aqueous suspension and confers molecular selectivity to their optical responses via (1) contributing to a molecular masking effect that defines the shape and size of the exposed surface of SWCNTs26-28 and (2) modulating their optical bandgaps29.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [26] Roxbury, D., Mittal, J. & Jagota, A. Molecular-basis of single-walled carbon nanotube recognition by single-stranded DNA. Nano Lett. 12, 1464–1469 (2012). source
Not checked in the free run.
- cites [27] Roxbury, D., Jagota, A. & Mittal, J. Structural characteristics of oligomeric DNA strands adsorbed onto single-walled carbon nanotubes. J. Phys. Chem. B 117, 132–140 (2013). source
Not checked in the free run.
- cites [28] Roxbury, D., Tu, X., Zheng, M. & Jagota, A. Recognition ability of DNA for carbon nanotubes correlates with their binding affinity. Langmuir 27, 8282–8293 (2011). source
Not checked in the free run.
- cites [29] Horoszko, C. P., Jena, P. V., Roxbury, D., Rotkin, S. V. & Heller, D. A. Optical voltammetry of polymer-encapsulated single-walled carbon nanotubes. J. Phys. Chem. C 123, 24200–24208 (2019). source
Not checked in the free run.
May combine two claims.
PremisecitationOCCs efficiently harvest mobile excitons through the SWCNT antenna, producing distinct E11− fluorescence bands and introducing new biochemical sensitivities to SWCNTs.
“OCCs efficiently harvest mobile excitons through the SWCNT antenna, producing distinct fluorescence bands (E11−) at longer wavelengths from the E11 band. The E11− fluorescence introduces new biochemical sensitivities to SWCNTs determined by the chemical nature of the defect, making OCCs the molecular focal points for local environmental responses32.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Kwon, H. et al. Optical probing of local pH and temperature in complex fluids with covalently functionalized, semiconducting carbon nanotubes. J. Phys. Chem. C 119, 3733–3739 (2015). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningOCC-DNAs exhibit relatively narrow bandwidths (35-80 meV), making small spectral shifts easier to resolve compared with conventional fluorophores (>100 meV).
“This is likely because OCC-DNAs exhibit relatively narrow bandwidths (35–80 meV), making small spectral shifts much easier to resolve compared with conventional fluorophores (>100 meV).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationMachine learning processes recognize disease-specific patterns that are too subtle or complex for human eyes or conventional analytical methods and aid in the construction of robust diagnostic models.
“Machine learning processes recognize disease-specific patterns that are too subtle or complex to be detected by human eyes or conventional analytical methods, and aid in the construction of robust diagnostic models17,18.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [17] Bera, K., Schalper, K. A., Rimm, D. L., Velcheti, V. & Madabhushi, A. Artificial intelligence in digital pathology—new tools for diagnosis and precision oncology. Nat. Rev. Clin. Oncol. 16, 703–715 (2019). source
Not checked in the free run.
- cites [18] Rajkomar, A. et al. Scalable and accurate deep learning with electronic health records. NPJ Digit. Med. 1, 18 (2018). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningPrediction outcomes will be lower in the clinical screening setting in which specimens are obtained in asymptomatic individuals before clinical diagnosis, because specimens obtained from symptomatic individuals at diagnosis were used for development and assessment.
“However, considering the fact that specimens obtained from symptomatic individuals at diagnosis were used for the development and assessment of the technology, prediction outcomes will be lower in the clinical screening setting in which specimens are obtained in asymptomatic individuals before clinical diagnosis.”
Quote in the paperSubstantial claim- Rests on an assumption: Serum biomarker profiles differ between symptomatic individuals at diagnosis and asymptomatic individuals before clinical diagnosis.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe risk of bias in the study was evaluated using PROBAST.
“The risk of bias in the study was evaluated on the basis of Prediction model Risk Of Bias Assessment, PROBLAST36 (Appendix 1 in Supplementary Information).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Wolff, R. F. et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann. Intern. Med. 170, 51–58 (2019). source
Not checked in the free run.
May combine two claims.
PremisecitationThe emission of SWCNTs (E11) is sensitive to dielectric environments, redox perturbations and electrostatic charge.
“The emission of SWCNTs (E11) is sensitive to dielectric environments21,22, redox perturbations23 and electrostatic charge24,25.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [21] Heller, D. A. et al. Optical detection of DNA conformational polymorphism on single-walled carbon nanotubes. Science 311, 508 (2006). source
Not checked in the free run.
- cites [22] Jena, P. V. et al. A carbon nanotube optical reporter maps endolysosomal lipid flux. ACS Nano 11, 10689–10703 (2017). source
Not checked in the free run.
- cites [23] Heller, D. A. et al. Multimodal optical sensing and analyte specificity using single-walled carbon nanotubes. Nat. Nanotech. 4, 114–120 (2009). source
Not checked in the free run.
- cites [24] Roxbury, D., Jena, P. V., Shamay, Y., Horoszko, C. P. & Heller, D. A. Cell membrane proteins modulate the carbon nanotube optical bandgap via surface charge accumulation. ACS Nano 10, 499–506 (2016). source
Not checked in the free run.
- cites [25] Williams, R. M. et al. Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant. Sci. Adv. 4, eaaq1090 (2018). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThere was no statistically significant difference in age distribution for each group.
“There was no statistically significant difference in age distribution for each group.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationThe imbalance in the size of each group was corrected by upscaling minority species (SMOTE) so that the prediction models were not biased by groups with larger sample sizes.
“The imbalance in the size of each group was corrected by upscaling minority species (SMOTE: Synthetic Minority Oversampling Technique)49 so that the prediction models were not biased by groups with larger sample sizes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] Chawla, N. V., Bowyer, K. W., Hall, L. O. & Kegelmeyer, W. P. SMOTE: synthetic minority over-sampling technique. J. Artif. Intell. Res. 16, 321–357 (2002). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll experiments were performed in triplicate.
“All experiments were performed in triplicate.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningModel performance was evaluated using 10-fold cross-validation to rule out possible overfitting in the machine learning process.
“To rule out possible overfitting in the machine learning process, model performance was evaluated using 10-fold cross-validation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenFor the biomarker prediction models, the data were divided into normal versus high biomarker level groups on the basis of clinical references (CA125, 50 U ml−1; HE4, 150 pM; YKL40, 1,650 pM) and the group size was corrected using SMOTE.
“For the biomarker prediction models, we divided the data into normal versus high biomarker level groups on the basis of clinical references (CA125, 50 U ml−1; HE4, 150 pM; YKL40, 1,650 pM) and corrected the group size using SMOTE.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenDiagnoses were identified from a chart review of each patient; all diagnoses included histology and were confirmed by a gynaecologic oncology attending physician.
“Diagnoses were identified from a chart review of each patient; all diagnoses included histology and were confirmed by a gynaecologic oncology attending physician.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenEach sample was measured in triplicate.
“Each sample was measured in triplicate.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe trained models were tested with an independent set of patient sera (N = 54), sampled from different patients, as external validation.
“The trained models were then tested with an independent set of patient sera (N = 54), sampled from different patients (test set), as external validation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataSix OCC-DNA nanosensors, with p-values of the spectroscopic features lower than 0.10, were selected for the sensor array.
“Six OCC-DNA nanosensors, with p-values of the spectroscopic features lower than 0.10, were selected for the sensor array.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The current best clinical screening test uses CA125 and transvaginal ultrasonography and has 84% sensitivity at 98% specificity.
“compared with 84% sensitivity at 98% specificity for the current best clinical screening test, which uses measurements of cancer antigen 125 and transvaginal ultrasonography”
The paper relies on this without support.
Earlier detection of ovarian cancer and timely measurements of disease progression and recurrence would markedly improve outcomes.
“The earlier detection of ovarian cancer and timely measurements of disease progression and recurrence would markedly improve outcomes.”
The paper relies on this without support.
Accurate detection of known analytes does not always confer high sensitivity and specificity for disease.
“However, accurate detection of known analytes does not always confer high sensitivity and specificity for disease.”
The paper relies on this without support.
Serum biomarker profiles differ between symptomatic individuals at diagnosis and asymptomatic individuals before clinical diagnosis.
“However, considering the fact that specimens obtained from symptomatic individuals at diagnosis were used for the development and assessment of the technology, prediction outcomes will be lower in the clinical screening setting in which specimens are obtained in asymptomatic individuals before clinical diagnosis.”
The paper relies on this without support.
The spectroscopic variables that are not sensitive to known biomarkers reflect the presence of unknown biomarkers or combinations thereof.
“This suggests that there exist potential biomarkers or combinations thereof that are either unknown or not part of conventional screening approaches but were captured by the OCC-DNA sensor array.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A nanosensor array technology combined with machine learning algorithms can distinguish between ovarian cancer patients and healthy individuals and predict ovarian cancer with high sensitivity and specificity.
“Kim et al. constructed a nanosensor array technology to identify disease spectral fingerprints and combined it with machine learning algorithms to successfully distinguish between ovarian cancer patients and healthy individuals, which can be used to predict ovarian cancer with high sensitivity and specificity.344”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [344]
The citation lists haven’t been fetched yet
References 51 · Cited by 214
Research works printed but not linked: 1
- Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
- Authors
- Kim, M., Chen, C., Wang, P., Mulvey, J. J., Yang, Y., Wun, C., Antman-Passig, M., Luo, H.-B., Cho, S., Long-Roche, K., Ramanathan, L. V., Jagota, A., Zheng, M., Wang, Y., & Heller, D. A.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of Maryland, College Park (US)
- Albert Einstein College of Medicine (US)
- Lehigh University (US)
- Hunter College (US)
- National Institute of Standards and Technology (US)
- Corresponding author
- Heller, Daniel A.
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2022-03-17
- Volume
- 6
- Issue
- 3
- Pages
- 267-275
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC9108893
- OpenAlex
- W4221014558
- Cited by
- 214
- References
- 51
- Citations by year
- 2026: 45 · 2025: 61 · 2024: 56 · 2023: 36 · 2022: 16
- FWCI
- 18.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01ca215719-05)
- National Cancer Institute (R01-CA215719, P30CA008748, U54CA137788, U54CA132378)
- National Institute of General Medical Sciences (R01GM114167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
- Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Keywords
- ovarian cancer, high-grade serous ovarian cancer, near-infrared fluorescence, spectral fingerprinting, serum biomarkers, cancer screening, machine learning classification, early cancer detection
- MeSH terms
- Machine Learning, Female, Humans, Ovarian Neoplasms, Biomarkers, Tumor, Nanotubes, Carbon, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review